A preliminary disease severity score for juvenile systemic sclerosis

Francesco La Torre, Giorgia Martini, Ricardo Russo, Maria Marta Katsicas, Fabrizia Corona, Giuseppina Calcagno, Fernanda Falcini, Fabio Vittadello, Francesco Zulian

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Objective To develop a preliminary disease severity score for juvenile systemic sclerosis (SSc). Methods We conducted an evidence- and consensus-based study that included the following 5 phases: 1) prospective collection of data regarding the demographic and clinical characteristics of patients with diffuse juvenile SSc who were followed up for at least 4 years or until death; 2) blinded evaluation of the disease course profiles of these patients by experts in juvenile SSc, so that patient profiles with a defined clinical course could be used as the gold standard for the score validation phase; 3) definition of candidate severity indices to be included in potential scores; 4) selection of the pediatric severity score with the best statistical performance, as determined by its ability to classify individual patients as having improvement or worsening of disease compared with baseline values or the previous evaluation; 5) validation of the efficiency of the selected score in patients with a mild, moderate, or severe disease course and comparison with the Medsger severity score for adults with SSc. Results Thirty-five patients classified as having a mild (n = 17), moderate (n = 10), or severe (n = 8) disease course entered the study. The selected pediatric SSc score, defined as the Juvenile Systemic Sclerosis Severity Score (J4S), included indices of 9 organ systems each scored on a scale of 0-4. To weight the importance of the involvement of different organ systems, a coefficient of severity was introduced. Compared with the modified Medsger severity score, the J4S performed significantly better in detecting change in severity, both in patients with a moderate disease course (0.89 versus 0.52) and in patients with a severe disease course (0.82 versus 0.75). Conclusion The J4S is a valid instrument to assess disease severity in juvenile SSc.

Original languageEnglish
Pages (from-to)4143-4150
Number of pages8
JournalArthritis and Rheumatism
Volume64
Issue number12
DOIs
Publication statusPublished - Dec 2012

Fingerprint

Systemic Scleroderma
Pediatrics
Diffuse Scleroderma
Demography
Weights and Measures

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Rheumatology
  • Pharmacology (medical)

Cite this

La Torre, F., Martini, G., Russo, R., Katsicas, M. M., Corona, F., Calcagno, G., ... Zulian, F. (2012). A preliminary disease severity score for juvenile systemic sclerosis. Arthritis and Rheumatism, 64(12), 4143-4150. https://doi.org/10.1002/art.34652

A preliminary disease severity score for juvenile systemic sclerosis. / La Torre, Francesco; Martini, Giorgia; Russo, Ricardo; Katsicas, Maria Marta; Corona, Fabrizia; Calcagno, Giuseppina; Falcini, Fernanda; Vittadello, Fabio; Zulian, Francesco.

In: Arthritis and Rheumatism, Vol. 64, No. 12, 12.2012, p. 4143-4150.

Research output: Contribution to journalArticle

La Torre, F, Martini, G, Russo, R, Katsicas, MM, Corona, F, Calcagno, G, Falcini, F, Vittadello, F & Zulian, F 2012, 'A preliminary disease severity score for juvenile systemic sclerosis', Arthritis and Rheumatism, vol. 64, no. 12, pp. 4143-4150. https://doi.org/10.1002/art.34652
La Torre F, Martini G, Russo R, Katsicas MM, Corona F, Calcagno G et al. A preliminary disease severity score for juvenile systemic sclerosis. Arthritis and Rheumatism. 2012 Dec;64(12):4143-4150. https://doi.org/10.1002/art.34652
La Torre, Francesco ; Martini, Giorgia ; Russo, Ricardo ; Katsicas, Maria Marta ; Corona, Fabrizia ; Calcagno, Giuseppina ; Falcini, Fernanda ; Vittadello, Fabio ; Zulian, Francesco. / A preliminary disease severity score for juvenile systemic sclerosis. In: Arthritis and Rheumatism. 2012 ; Vol. 64, No. 12. pp. 4143-4150.
@article{2ccef43ea0b8404ea81dba980f9a8fed,
title = "A preliminary disease severity score for juvenile systemic sclerosis",
abstract = "Objective To develop a preliminary disease severity score for juvenile systemic sclerosis (SSc). Methods We conducted an evidence- and consensus-based study that included the following 5 phases: 1) prospective collection of data regarding the demographic and clinical characteristics of patients with diffuse juvenile SSc who were followed up for at least 4 years or until death; 2) blinded evaluation of the disease course profiles of these patients by experts in juvenile SSc, so that patient profiles with a defined clinical course could be used as the gold standard for the score validation phase; 3) definition of candidate severity indices to be included in potential scores; 4) selection of the pediatric severity score with the best statistical performance, as determined by its ability to classify individual patients as having improvement or worsening of disease compared with baseline values or the previous evaluation; 5) validation of the efficiency of the selected score in patients with a mild, moderate, or severe disease course and comparison with the Medsger severity score for adults with SSc. Results Thirty-five patients classified as having a mild (n = 17), moderate (n = 10), or severe (n = 8) disease course entered the study. The selected pediatric SSc score, defined as the Juvenile Systemic Sclerosis Severity Score (J4S), included indices of 9 organ systems each scored on a scale of 0-4. To weight the importance of the involvement of different organ systems, a coefficient of severity was introduced. Compared with the modified Medsger severity score, the J4S performed significantly better in detecting change in severity, both in patients with a moderate disease course (0.89 versus 0.52) and in patients with a severe disease course (0.82 versus 0.75). Conclusion The J4S is a valid instrument to assess disease severity in juvenile SSc.",
author = "{La Torre}, Francesco and Giorgia Martini and Ricardo Russo and Katsicas, {Maria Marta} and Fabrizia Corona and Giuseppina Calcagno and Fernanda Falcini and Fabio Vittadello and Francesco Zulian",
year = "2012",
month = "12",
doi = "10.1002/art.34652",
language = "English",
volume = "64",
pages = "4143--4150",
journal = "Arthritis care and research : the official journal of the Arthritis Health Professions Association",
issn = "0893-7524",
publisher = "John Wiley and Sons Inc.",
number = "12",

}

TY - JOUR

T1 - A preliminary disease severity score for juvenile systemic sclerosis

AU - La Torre, Francesco

AU - Martini, Giorgia

AU - Russo, Ricardo

AU - Katsicas, Maria Marta

AU - Corona, Fabrizia

AU - Calcagno, Giuseppina

AU - Falcini, Fernanda

AU - Vittadello, Fabio

AU - Zulian, Francesco

PY - 2012/12

Y1 - 2012/12

N2 - Objective To develop a preliminary disease severity score for juvenile systemic sclerosis (SSc). Methods We conducted an evidence- and consensus-based study that included the following 5 phases: 1) prospective collection of data regarding the demographic and clinical characteristics of patients with diffuse juvenile SSc who were followed up for at least 4 years or until death; 2) blinded evaluation of the disease course profiles of these patients by experts in juvenile SSc, so that patient profiles with a defined clinical course could be used as the gold standard for the score validation phase; 3) definition of candidate severity indices to be included in potential scores; 4) selection of the pediatric severity score with the best statistical performance, as determined by its ability to classify individual patients as having improvement or worsening of disease compared with baseline values or the previous evaluation; 5) validation of the efficiency of the selected score in patients with a mild, moderate, or severe disease course and comparison with the Medsger severity score for adults with SSc. Results Thirty-five patients classified as having a mild (n = 17), moderate (n = 10), or severe (n = 8) disease course entered the study. The selected pediatric SSc score, defined as the Juvenile Systemic Sclerosis Severity Score (J4S), included indices of 9 organ systems each scored on a scale of 0-4. To weight the importance of the involvement of different organ systems, a coefficient of severity was introduced. Compared with the modified Medsger severity score, the J4S performed significantly better in detecting change in severity, both in patients with a moderate disease course (0.89 versus 0.52) and in patients with a severe disease course (0.82 versus 0.75). Conclusion The J4S is a valid instrument to assess disease severity in juvenile SSc.

AB - Objective To develop a preliminary disease severity score for juvenile systemic sclerosis (SSc). Methods We conducted an evidence- and consensus-based study that included the following 5 phases: 1) prospective collection of data regarding the demographic and clinical characteristics of patients with diffuse juvenile SSc who were followed up for at least 4 years or until death; 2) blinded evaluation of the disease course profiles of these patients by experts in juvenile SSc, so that patient profiles with a defined clinical course could be used as the gold standard for the score validation phase; 3) definition of candidate severity indices to be included in potential scores; 4) selection of the pediatric severity score with the best statistical performance, as determined by its ability to classify individual patients as having improvement or worsening of disease compared with baseline values or the previous evaluation; 5) validation of the efficiency of the selected score in patients with a mild, moderate, or severe disease course and comparison with the Medsger severity score for adults with SSc. Results Thirty-five patients classified as having a mild (n = 17), moderate (n = 10), or severe (n = 8) disease course entered the study. The selected pediatric SSc score, defined as the Juvenile Systemic Sclerosis Severity Score (J4S), included indices of 9 organ systems each scored on a scale of 0-4. To weight the importance of the involvement of different organ systems, a coefficient of severity was introduced. Compared with the modified Medsger severity score, the J4S performed significantly better in detecting change in severity, both in patients with a moderate disease course (0.89 versus 0.52) and in patients with a severe disease course (0.82 versus 0.75). Conclusion The J4S is a valid instrument to assess disease severity in juvenile SSc.

UR - http://www.scopus.com/inward/record.url?scp=84870354772&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870354772&partnerID=8YFLogxK

U2 - 10.1002/art.34652

DO - 10.1002/art.34652

M3 - Article

VL - 64

SP - 4143

EP - 4150

JO - Arthritis care and research : the official journal of the Arthritis Health Professions Association

JF - Arthritis care and research : the official journal of the Arthritis Health Professions Association

SN - 0893-7524

IS - 12

ER -